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Abstract. The Precision Medicine Initiative states that treatments for
a patient should take into account not only the patient’s disease, but
his/her specific genetic variation as well. The vast biomedical literature
holds the potential for physicians to identify effective treatment options
for a cancer patient. However, the complexity and ambiguity of medical
terms can result in vocabulary mismatch between the physician’s query
and the literature. The physician’s search intent (finding treatments in-
stead of other types of studies) is difficult to explicitly formulate in a
query. Therefore, simple ad hoc retrieval approach will suffer from low
recall and precision.
In this paper, we propose a new retrieval system that helps physicians
identify effective treatments in precision medicine. Given a cancer patient
with a specific disease, genetic variation, and demographic information,
the system aims to identify biomedical publications that report effective
treatments. We approach this goal from two directions. First, we expand
the original disease and gene terms using biomedical knowledge bases
to improve recall of the initial retrieval. We then improve precision by
promoting treatment-related publications to the top using a machine
learning reranker trained on 2017 Text Retrieval Conference Precision
Medicine (PM) track corpus. Batch evaluation results on 2018 PM track
corpus show that the proposed approach effectively improves both recall
and precision, achieving performance comparable to the top entries on
the leaderboard of 2018 PM track.
1 Introduction
Mr. H is a 35-year-old man who has had a cough for a couple of months. After
having an x-ray and CT scan, he was diagnosed as having non–small cell lung
cancer. However, he has always kept a healthy lifestyle and never smoked. One
possible answer could be that his disease is caused by some gene mutations. Had
his cancer been diagnosed in the past, his physician might have treated him just
like other patients with lung cancers caused by smoking. But if his disease is
diagnosed recently, his biopsy tissue could be analyzed for a panel of genetic
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variants that can reliably predict what treatment would be most effective for
him [1].
This scenario reveals the core idea of precision medicine: based on genetic,
biomarker and demographic data, finding a personalized treatment which is dif-
ferent from treatments for other patients with similar clinical symptoms for a
specific patient. According to the Precision Medicine Initiative launched by the
former President Barack Obama in 2015, precision medicine is an approach for
disease treatment and prevention that takes into account individual variability
in genes, environment, and lifestyle for each person. This approach will allow
physicians to conduct treatments more accurately. It is in contrast to the one-
size-fits-all approach, in which treatments are developed for all the people with
the same disease, with less consideration for the differences between individuals
[2]. One example of precision medicine is finding treatments according to the
genes of that patient, as genomic sequencing can be used as a molecular micro-
scope to classify disease according to their specific abnormal biology. A study
supports that in 96% of undiagnosed primary tumors, a genomic alteration could
be identified and that in 85% of these cases, it is potentially treatable by a known
drug [3].
The origin of precision medicine could date back to the fact that a person
who needs a blood transfusion is not given blood from a randomly selected donor,
but it was impossible to fulfill this goal in the past. The reduced cost of sequenc-
ing a human genome ($22 million ten years ago versus $1,000 to $5,000 now)
and time of sequencing (2 years ten years ago versus 1 day now) has made the
precision medicine idea more possible today [4]. Also, the adoption of Electronic
Health Record (EHR) systems in hospitals has grown from below 30% to over
90%. These systems can help physicians to find relevant and useful information
about a patient to inspire and support their decisions. Such information is help-
ful in evidence-based analysis. In early days, physicians would input patient’s
demographic data and symptoms, searching for information in a EHR system
to conduct disease diagnosis. They analyze the data to determine the patho-
physiologic explanation, or to find potential treatment by referring to previous
treatments for patients with similar symptoms [5].
Although such kind of analysis which is based on previous evidence and
records may still work today, in most cases however, academic literature could
provide more comprehensive knowledge and scientific support for decision-making
with more reliability, and physicians can learn about the latest research of and
treatments for a disease as well. The ability to personalize treatment in a scien-
tifically rigorous manner is thus the hallmark of the emerging precision medicine
paradigm. However, due to the huge volume of academic articles which keeps
growing rapidly, it is not easy to build an effective Information Retrieval (IR)
system for searching medical literature. Clinicians can easily be overwhelmed
by the great number and be inhibited to determine the best possible treatment
because hardly do they have enough time to go through each paper they find.
It would be much more difficult if a clinician wants to find some papers which
exactly match the genetic, disease and demographic information of his patient.
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physicians could be provided with an effective IR system to easily retrieve rel-
evant medical literature when making decisions, the gap between theoretical
setting and real-world clinical setting could be fixed.
For many years, people have been studying how to make medical literature
retrieval systems more effective. In the Interactive Information Retrieval research
area, according to a survey by Lu [6], some approaches have been proposed to
improve the retrieval system for better usability, e.g., changing the searching in-
terface which helps users to discover and identify potentially relevant documents.
Steinbrook uses the information seeking and information behavior theory to pro-
pose better literature searching skills for physicians [7]. But these studies do not
make great contributions to retrieval systems on the technical level. To promote
research for better IR systems in medical literature searching, the National Insti-
tute of Standards and Technology (NIST) has organized the Precision Medicine
(PM) track since 2017 in the Text Retrieval Conference (TREC). The biomed-
ical abstract task in the PM track uses a real-world setting as discussed above.
Suppose a physician is given a patient’s disease, gene and demographic informa-
tion, how could the IR system help him to retrieve relevant medical literature
for conducting treatments?
The problem is very straightforward, but why is it difficult to build an ef-
fective IR system for medical literature searching? The first answer is the great
volume of articles in the corpus. PubMed1, which is a free search engine access-
ing the MEDLINE database of biomedical topics, has more than 29.1 million
records with about 500,000 new records being added each year, according to its
Wikipedia page2. Besides, the vocabulary problem has been found to be a big
hurdle, and the vocabulary mismatch between queries and documents is recog-
nized as a common failure in many IR systems. This problem has also been well
noted in the health domain [8]. The vocabulary problem could be interpreted
from two aspects. The first aspect comes from obscure medical terminologies and
a variety of abbreviations and variations. For example, BRAF 3 is a human gene
which is also referred to as proto-oncogene B-Raf, and it has some aliases like
B-RAF1, BRAF1 and etc. When a document only includes these aliases instead
of the original term, it will not be retrieved if a simple Boolean retrieval strategy
is used. The second aspect is that physicians may have varying domain knowl-
edge, which affects how they pose the query. User queries have been found to be
very short with only two to three words, and query terms are significant different
from terms in professional thesauri [9]. If the physician is not very familiar with
the domain thesauri, he may have difficulties in formulating a well-structured
query. In other words, a physician may input a disease or gene term into the
query purely based on his understanding and preferred usage of medical terms,
which is probably due to the lack of a unified form for a single concept. Using dif-
ferent terms to describe the same concept could even happen among researchers
1 https://www.ncbi.nlm.nih.gov/pubmed/
2 https://en.wikipedia.org/wiki/PubMed
3 https://en.wikipedia.org/wiki/BRAF_(gene)
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with comparable level of knowledge on the subject. It is almost impossible for
a physician to input all the relevant terms into the query by looking up the
term in a thesaurus or an ontology when he attempts to do retrieval. Apart
from previous difficulties, even if a physician could formulate a well-structure
query and retrieve more relevant documents than he used to, a powerful ranking
algorithm is also necessary, considering a physician’s limited time to read only
several documents appearing at the top.
In this paper, we propose a new retrieval architecture. We use query expan-
sion to tackle the vocabulary problem by automatically looking up the original
disease and gene terms in knowledge bases and adding expansion terms into the
query. We aim to retrieve more potentially relevant documents which do not
explicitly mention the target disease or gene terms to optimize recall. After this
step, we train a Logistic Regression classifier and apply it to the retrieved re-
sult to predict the probability of how relevant a document is to the PM track,
and we aim to use the probability to re-rank the result to optimize precision. It
should be noted that the term classifier and reranker are used interchangeably in
this paper. The dataset provided by the PM track which consists of 26.8 million
MEDLINE articles and 70,026 ASCO/AACR conference articles serves as our
corpus. For training the classifier and tuning parameters, we use the 30 topics
from the 2017 track as our training set, and all the retrieval tasks for testing use
the 50 topics from the 2018 track.
The paper proceeds as follows. The literature review section provides some
preliminary knowledge of the techniques used in this paper and current research
in medical literature IR systems as well. The method section introduces how
the query is expanded and how the classifier is trained to re-rank the retrieved
results. The experiment section shows technical details in implementing the ar-
chitecture, the comparison between several retrievals with different strategies
and several case studies to support why our architecture works. Finally, the con-
clusion section summarizes all the work in this paper and provides an outlook
for the further work.
2 Literature Review
In this section, we review relevant literature to provide an overview of the re-
search background and related works mainly from three aspects: query expansion
and learning-to-rank in IR systems, applications of knowledge bases in IR sys-
tems, and different approaches to improve medical literature IR systems so far.
2.1 Query Expansion
Different people may use quite different words to describe a same object. There-
fore, traditional IR systems which only use keywords in the query to match terms
in documents are not effective in some cases because the information about a
same issue can be expressed in different words that may not be exactly the same.
5A document could still be relevant without the exact terms from the query, as
long as it has other words with the same meaning.
When a query contains multiple terms regarding to a user’s desired informa-
tion, the result could be satisfying with a relatively high recall. However, if a user
has poor domain knowledge and the query is short with ambiguous or misspelled
words, there might be few relevant documents retrieved. For instance, the exam-
ple of BRAF in the previous section is common in the medical domain, because
many medical terms have aliases and variations and are written in full name
or in abbreviation interchangeably. This is the vocabulary mismatch problem
which leads to the ineffectiveness of traditional information retrieval systems. It
is also where the motivation of query expansion comes.
Query expansion enhances the original query with other words which are
most likely to capture user’s desired information. The core idea is to generate
an alternative or expanded query for the user. One intuitive way is to add into
the query some synonyms or relevant terms of each keyword by looking up in
a thesaurus or discovering term relations like their co-occurrences in documents
[10]. Basically, there are two approaches of query expansion: the corpus-based
approach which generates expansion terms from documents ranking at the top
with the assumption that the most frequent terms appearing in these documents
are highly correlated to the original query, and the resource-based approach
which leverages external resources like domain-specific dictionaries, ontologies,
or knowledge bases to add expansion terms into the original query. In other
words, the first approach depends on the searching process and uses relevance
feedback in iteration of searching to identify expansion terms, while the second
approach is independent of the searching process and additional expansion terms
are derived from a knowledge structure.
In the corpus-based expansion approach, relevance feedback is a represen-
tative technique that is widely used to improve retrieval performances. The
relevance feedback process usually happens after a retrieval is done, and the
original query is reformulated according to the retrieval result. Relevance feed-
back could further be split into two methods which are implicit and explicit. The
explicit method asks users to mark documents in the retrieval result as relevant
or irrelevant. Then based on the feedback, the algorithm computes a better rep-
resentation of the information, from which a revised query is formulated and a
new retrieval is run. A classical method is the Rocchio algorithm [11], which adds
an arbitrary percentage of relevant and minuses that of non-relevant documents
to the original query in a vector space model. Apart from the explicit method
with manual input, Pseudo Relevance Feedback (PRF), also known as blind rel-
evance feedback, is also widely used. It automates the manual part so that the
user gets improved retrieval performance without an extended interaction. This
approach runs a query to find an initial set of most relevant documents, then
makes the assumption that the top K documents are all relevant and revise the
query under this assumption.
In the resource-based expansion approach, there are well-structured knowl-
edge resources developed by domain experts in some specific domains, which pro-
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vide expansion terms based on relations between entries. Expansion terms with
certain relations to the original query terms are generated from these knowledge
bases.
However, although query expansion helps to capture user’s real information
needs, the additional terms may cause the drift of the focus of a search topic
caused by improper expansion and may hurt the retrieval performance in both
precision and recall. Therefore, apart from generating expansion terms arbitrar-
ily, a lot of studies show that the quality of added terms and weights assigned to
these expansion terms could largely affect the result of retrieval. In the medical
IR area, Xu et al. used PRF to generate expansion terms which are mapped
into MeSH, and refined the candidate expansion terms by training term-ranking
models to select the most relevant ones for query expansion [12].
2.2 Learning-to-rank
The goal of ranking in IR is to generate a ranked list of retrieval results according
to their relevance to the original query. Usually a ranking model computes a score
between the document and the query to measure their relevance, and the results
are ranked in a descending order by the score. Basic IR models like Boolean
retrieval could only tell whether a document is relevant or not, but could not
tell how relevant a document is. Therefore, the vector space model, language
model and other models are introduced to compute the relevance scores. For
example, in the vector space model, documents and queries are represented by
vectors with TFIDF weights. Then the relevance score is computed by the cosine
similarity between two vectors. In the language model, a maximum likelihood
method is used to compute the probability to measure the relevance. These
ranking models have been widely used in a lot of studies as well as some industry-
level applications.
However, one drawback of these traditional ranking models is that there are
some parameters which need to be tuned in a heuristic way to get a reasonable
result. Apart from the fact that parameter tuning is a time-consuming and triv-
ial task, a model tuned on the validation set sometimes performs very poorly on
unseen test queries [13]. Recently years, machine learning has been demonstrat-
ing its power in various areas on a lot of tasks. In IR, we could also leverage
machine learning techniques on ranking models to do automatically parameter
tuning and avoid the overfitting problem.
Adopting the idea of supervised learning, learning-to-rank methods construct
the loss function by incorporating the ranking-based information. Same as other
supervised learning methods, data are split into training data and test data.
Suppose that there is a corpus of documents, and the ranking model is thus
trained by a number of queries and each query is associated with a set of re-
trieved documents with relevance judgments. In testing, given a new query, the
ranking function is supposed to create a precise ranked list for retrieval results
[14]. There are three different types of learning-to-rank methods, which are the
pointwise approach, the pairwise approach and the listwise approach. And these
three methods model takes a single document, a pair of documents and a list
7of documents as instances for learning respectively [13]. In training the model,
since the document-query are represented in multi-dimensional feature vectors,
the selection of features plays an important role regarding to the ranking perfor-
mance.
2.3 Medical Information Retrieval
The quantity of medical articles keeps increasing rapidly, which puts much pres-
sure on medical specialists who need to be aware of up-to-date studies, and
physicians who need academic papers as references to diagnose diseases and find
treatments. The current retrieval systems for medical literature, however, are
not efficient and the searching task is still time-consuming.
There are a lot of studies proposing different methods to improve medical
literature searching systems. Lu did a survey of 28 medical literature search-
ing systems which were built between 1999 to 2010, and sixteen of them were
implemented based on the PubMed system with minor adjustments [6]. These
improvements are summarized into four development themes: (1) a new ranking
of searching results from the default reverse chronological order to relevance, (2)
clustering results into topics for quicker navigation, (3) extracting and display-
ing semantic relations from results, and (4) improving searching interfaces and
retrieval procedures to make the system more user-friendly. However, these im-
provements were made on the usability level, few changes have been made on
the technical level.
In recent years, with the development of technologies and the devotion of
human efforts, there are more and more knowledge bases in the medical do-
main, and these resources are becoming well-structured and comprehensive with
a large size. There are some remarkable knowledge bases in the medical domain,
e.g., the Medical Subject Headings (MeSH), the Unified Medical Language Sys-
tem (UMLS), Orphanet and etc. Many studies have successfully incorporated
these knowledge bases into IR systems to improve retrieval performances, or
to solve the mismatch problem. Martinez et al. presented an automatic query
expansion method based on random walks over the UMLS graph with applica-
tions in the EHR record searching, and showed that query expansion improved
the robustness of the system [15]. Otegi et al. explored semantic relatedness
techniques to propose a generic method using structured knowledge for both
query and document expansion to improve results, and showed that their meth-
ods are complementary with PRF [16]. Koopman et al. proposed a medical IR
system that integrates structured knowledge resources, statistical methods, and
semantic inference in a Graph Inference retrieval model to tackle the semantic
gap problem [17]. Mao et al. proposed a new medical IR system which assigns
MeSH terms to documents and then quantifies associations between documents
and assigned concepts to construct conceptual representations, thus uses the
generative concept models match queries and documents [18]. Moreover, several
studies add knowledge bases into the system to extract latent concepts and rela-
tions for query expansion. Griffon et al. proposed that terms in documents could
be mapped into UMLS to find synonyms to be added into the original queries
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[19]. Jalali and Borujerdi used the MeSH knowledge base and proposed a query
expansion method to match concept pairs between queries and documents. They
also pointed out that gene knowledge bases are another source for expansion [20].
Since 2017, the precision medicine track has been added to TREC, and a
lot of approaches to improve IR systems for medical literature searching have
been proposed by teams participating in the track. Wang et al. explored the
simplest approach that the NCI thesaurus and COSMIC are used to expand
disease and gene terms with synonyms, and the retrieval result proved that the
simplest method already significantly improved the retrieval performance [21].
Liu et al. explored an iterative approach to construct the query which starts
from the strictest situation with exact matching of diseases and genes, i.e., terms
must match, to relaxed matching, i.e., some terms may and some terms may not
match, and finally to lenient match, i.e., terms may or may not match. The
ranked retrieval list is then produced based on the iteration of these queries [22].
Zheng et al. explored assigning different weights for different parts in the query
and proposed that the weight for disease, gene, gene mutation and general disease
term should be in a descending order [23]. Zhou et al. constructed a knowledge
graph which contains the relations between gene, cancer and drug pairs from
several knowledge bases via knowledge extraction and identifier normalization.
Then this knowledge graph serves for both query expansion and re-ranking. A
classifier which combines Recurrent Neural Network and Convolutional Neural
Network is also trained for re-ranking to retrieved documents [24].
3 Method
In this section, we first give an overview of our proposed retrieval architecture
with two parts of indexing and searching. We then introduce the core techniques
to improve retrieval which consists of two consecutive steps: the query expan-
sion step which aims at improving recall and the re-ranking step which aims at
improving precision. In the re-ranking section, we discuss how the classifier is
trained and how features are generated. Our goal is to retrieve as many relevant
documents as possible at the first step, and then re-rank the retrieved results
using the reranker to push the most relevant documents to the top. In other
words, in the final retrieval result, we expect a higher-precision and higher-recall
performance than the baseline strategy.
3.1 Retrieval Architecture
As shown in Figure 1, our novel retrieval architecture consists of three parts: the
processing and indexing part which converts the corpus into Lucene indexes, the
parameter tuning and classifier training part which uses the 30 topics in 2017 to
get optimized weights for expansion terms and a linear classifier for re-ranking,
and the final retrieval part to test our proposed strategies which uses the 50
topics in 2018. All the 2017 and 2018 query topics are expanded from the same
knowledge bases. We tune and train the model using topics from 2017 and treat
9Fig. 1. An overview of the retrieval architecture
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the 2018 topics as a black box to ensure the robustness of the model. Finally,
we simply apply the same pipeline to the 2018 topics to get a ranked list of
documents for relevance judgment.
Indexing We use Apache Lucene4 6.0.0, which is an open-source, high-performance
and publicly-available searching engine toolkit in Java as our main system frame-
work for indexing and searching.
For each paper in the corpus, we index five fields which are document ID, title,
content, publication type and MeSH headings (see Table 1). It is important to
note that the corpus only contain the abstract part of a paper instead of its full
text, which is referred as the content in this paper. Only the title and abstract
field are analyzed with the built-in standard analyzer, which mean that these
two fields are tokenized and used to match the query for relevance measurement.
Also, there are 599 documents with slightly different abstract but the same
document ID, for a paper is added into the corpus every time after it is revised.
We simply index a document at the first hit and ignore the later versions to
prevent duplicate document IDs in the retrieved result. Throughout the whole
architecture, we use the Okapi BM255 scoring algorithm which has been widely
used in various industry-level applications. Compared to the traditional TF-IDF
scoring function, BM25 has more reasonable scoring functions and more flexible
parameters to be tuned. In this paper, we use the default parameter settings of
1.25 and 0.75 for all the retrieval task.
Table 1. Five fields indexed for each scientific paper
Fields Analyzed Stored
Title True True
Abstract True True
ID False True
Publication Type False True
MeSH Heading False True
Given a query Q, containing keywords q1,...,qn, the BM25 score of a document
D to the query is calculated as:
Score(D,Q) =
N∑
i=1
IDF (qi) ∗
f(qi, D) ∗ (k1 + 1)
f(qi, D) + k1 ∗ (1− b + b ∗
|D|
avgdl
)
(1)
where f(qi,D) is query term qi’s term frequency in the document D, |D| is
the length of document D (total number of words), avgdl is the average docu-
ment length in the corpus, k1 and b are hyperparameters. IDF(qi) is the inverse
4 http://lucene.apache.org/
5 https://en.wikipedia.org/wiki/Okapi_BM25
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document frequency (IDF) weight of query term qi, which is usually computed
as:
IDF (qi) = log
N − n(qi) + 0.5
n(qi) + 0.5
(2)
where N is the total number of documents in the collection and n(qi) is the
number of documents which contain the query term qi.
Training and testing All the training and parameter tuning tasks are done
on the 2017 topics, with the released relevance judgement file which contains
the true relevance scores of some documents in the corpus. In both training and
testing processes, the queries are first expanded using the same knowledge bases
which are introduced in the query expansion section, and the initial weight for
each expansion term is set to 0.3 to ensure the expansion terms do not shift the
focus of the original query too much.
Since the standard number of retrieved documents for each topic is 1000, we
use the metric of Recall@1000 to evaluate the retrieval after query expansion,
which is calculated as the number of relevant documents in the retrieved 1000
results divided by the total number of relevant documents in the corpus. Then
we tune the weight parameters for expansion terms to optimize R@1000, which
desires to retrieve as many relevant documents as possible. The results of opti-
mal weight parameters are shown in detail in the experiment section. Another
significant contribution of the 2017 topics is to train a linear classifier which
predicts the probability of a document’s being relevant to the PM track. Af-
ter generating high-level features from the text, we train a Logistic Regression
model for binary classification in which labels are only relevant or non-relevant.
This process is introduced in detail in the re-ranking section. After getting a
set of weight parameters optimizing R@1000 and a trained Logistic Regression
classifier, we apply the same process on the 2018 topics for testing.
3.2 Query Expansion
The goal of query expansion is to use external knowledge bases to expand the
original term which helps the query to match more documents which do not
contain that term. Since both disease and gene information are given regarding
to a patient, we expand both two fields in knowledge bases separately.
Diseases There are a lot of knowledge bases in the general domain, e.g., Wikipedia
6 and DBpedia7, and Medical Subject Headings (MeSH)8 from NCBI in the med-
ical domain. Most research in medical IR systems use the MeSH knowledge base
because of its coverage and authority. However, in this paper we use another
6 https://www.wikipedia.org/
7 https://wiki.dbpedia.org/
8 https://www.ncbi.nlm.nih.gov/mesh
12 J. Qu and Y. Wang
knowledge base called Lexigram9 which is a publicly-available API. It contains
not only the MeSH ontology, but also other knowledge bases like the Systematic
Nomenclature of Medicine Clinical Terms (SNOMED CT) and the International
Classification of Diseases (ICD). By integrating three professional knowledge
bases together, this knowledge base provides broader and more accurate terms
for disease expansion. Both MeSH and Lexigram support finding the preferred
term, synonyms, as well as parent disease and children disease of a given disease
term in a hierarchical structure.
In selecting an appropriate query expansion structure, at first we include
all these expansion terms, but we find the parent and children expansion terms
bring too many noises into the original query. It makes the retrieved documents
either too broad or too specific, and the result is low in both recall and preci-
sion. Therefore, in the final query expansion for diseases, parent and children
disease terms are discarded. The table below illustrates how expansion terms for
a disease term are different in two medical knowledge bases (see Table 2).
Table 2. Example of disease expansion terms in two different knowledge bases
Knowledge Bases Lexigram MeSH
Original Disease Term cholangiocarcinoma cholangiocarcinoma
Preferred Term cholangiocarcinoma of biliary tract cholangiocarcinomas
Synonyms bile duct carcinoma, Intrahepatic Cholangio-
bile duct adenocarcinoma, carcinoma, Extrahepatic
cholangiocellular carcinoma Cholangiocarcinoma
Another edge of using the Lexigram knowledge base is that it can recognize
disease terms from input text and automatically generate expansion terms. How-
ever, if using the MeSH knowledge base, we need to look up the disease in MeSH
first to get a unique identifier, and then retrieve expansion terms according to
that identifier. This brings a problem that when the disease in the query topic is
a rare disease or do not match the standard disease name in MeSH, the identifier
is hard to be found and no results could be retrieved from the ontology.
Apart from the preferred term and synonyms, acronyms are also used as
expansion terms in this paper. Consider such a snippet in a paper’s abstract
which is relevant to lung cancer :
“Microarray analyses have revealed significantly elevated expression
of the proto-oncogene ROS1 receptor tyrosine kinase in 20-30% of
non-small cell lung carcinomas (NSCLC). Selective and po-
tent ROS1 kinase inhibitors have recently been developed and onco-
genic rearrangement of ROS1 in NSCLC identified. We performed
immunohistochemical evaluation of expression of ROS1 kinase and
its downstream molecules in 399 NSCLC cases. ROS1 expression
9 https://www.lexigram.io/
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in primary and recurring lesions of 92 recurrent NSCLC cases was
additionally analyzed.”
In this text, we can clearly see that the disease non-small cell lung carcino-
mas is only written in its full name when it appears in the paragraph for the
first time. Then it is written in its acronym form NSCLC afterwards for simplic-
ity. This is very common in biomedical scientific papers that people use short
acronyms instead of full names because of the length. Therefore, if the query
does not include the acronym of a disease, some relevant papers could not be
matched or not rank in the top because of the low term frequency of the original
disease terms. However, to best of our knowledge, there does not exist a publicly
available acronym dictionary or API which automatically maps a disease term
to its acronym. For this paper, we simply use such a regular expression Disease
Name ([A-Z]+) in the corpus to match a pattern that a disease name is followed
by a capitalized term in parentheses to retrieve acronyms for each disease.
Genes For query expansion of the gene field, we enrich the original gene term
with the genetic dataset provided by the National Center for Biotechnology
Information (NCBI)10. We simply include the aliases for each gene term by
looking it up in the dataset (see Table 3).
Table 3. Example of gene expansion terms in the NCBI gene list
Knowledge Bases NCBI gene list
Original Gene Term KRAS
Aliases C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B
K-Ras|KI-RAS|KRAS1|KRAS2|NS|NS3|RALD|c-Ki-ras2
To summarize, for each query topic the disease term is expanded to its pre-
ferred term, acronym and synonyms, and the gene term is expanded to its aliases.
This process assists to enrich the information in the original query and thus
match those potentially relevant documents which do not mention the original
disease or gene term but terms referring to the same disease or gene. In common
practice, the expansion terms usually have a lower weight than the original term,
in case they introduce too many noises and shift the focus of the original query.
Following a heuristic approach, we give the highest priority to the original dis-
ease and gene term with a weight of 1, and give a weight between 0 and 1 to
decrease the importance of expansion terms. This is supposed to help to improve
R@1000 and not to hurt precision at the same time. We then tune these weight
parameters on the 2017 topics and the result is in the experiment section.
10 ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/
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3.3 Re-ranking
Although with query expansion we may optimize R@1000 to retrieve more rele-
vant documents than before, we are still in need of an effective ranking method
which pushes the most relevant documents to the top. In the real-world setting,
it is impossible for physicians to go through all the 1000 papers retrieved, and
their focus should only be on the documents ranking at the top. Therefore, the
PM track evaluate the retrieved result by P@10 and R-precision, which calls for
a high precision of the retrieval. In this section, we discuss our work of re-ranking
to optimize P@10, which is calculated as the number of relevant documents in
the top 10 results divided by 10. We present a heuristic approach first, followed
by the learning-to-rank approach.
A Heuristic Approach Before starting training the reranker which helps to
judge how relevant a document is relevant or how much a document is relevant
to the PM topics, we explore a heuristic approach to re-ranking the retrieved
results.
First we print out the title and content of retrieved results after the query
expansion and examine the top 10 articles for each topic to investigate the most
intuitive characteristics of relevant and non-relevant documents. We notice that
on the average of 30 topics, almost all the relevant articles have the disease
term in the title and most of the non-relevant articles do not. Therefore, we
hypothesize that a relevant article should have the disease term in the title
and it is an important characteristic, otherwise it shall be penalized to a lower
relevance score. Based on this idea, we explore a heuristic approach of punishing
those articles without the disease term by multiplying their original scores with
a penalty factor between 0 to 1.
To select an approximate penalty factor, we investigate how to push a relevant
document which has the disease term in its title and the highest ranking outside
the top 10, i.e., ranking at 11, 12, etc., to the top 10. Thus, our goal is to find
the gap between such a relevant article and a non-relevant document which does
not have the disease term in its title and the highest ranking in the top 10. In
other words, we push relevant documents upwards by giving the positions of
non-relevant documents.
Finally, we find scores of such relevant documents are around 0.6 of scores of
such non-relevant documents on the average of 30 topics. We thus set the penalty
factor to 0.6, and the performance of this retrieval shown in the experiment
section proves that simple as this heuristic approach is, it does help to push
relevant documents upwards and to improve Precision@10.
Learning to Rank The heuristic approach is the starting point of re-ranking
the retrieved result to enhance P@10. However, this approach is based on hu-
man efforts of reading and examining the results, and such method may not
be robust. Therefore, apart from this approach, we aim to leverage the point-
wise learning-to-rank idea and machine learning techniques to learn a ranker
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which can automatically tell whether a paper is relevant to the PM track or not.
The feature of whether the disease term appears in the article title shows its
usefulness above. Table 4 lists query-document features and document-specific
features used in the ranker. We choose high-level features instead of pure word
features from the bag-of-words model because such features would be too sparse
to have a good performance.
First, we hypothesize that an article which is relevant to the topic or in accord
with the precision medicine track should focus on treatments and diagnosis of
patients, and should not talk about laboratory experiments or some general
topics. Second, since each article has the information of its publication types,
e.g., journal article, review, case study, clinical trial and etc., we hypothesize
that an article with the type of clinical trial should have a higher probability
of being relevant. Third, each article has the information of its MeSH headings
to imply what its content is mainly about, e.g., Humans, Mutation, genetics,
and etc. It is similar to keywords in other scientific papers but uses the MeSH
thesaurus. We hypothesize that an article with certain headings should be more
likely to be a relevant one.
The features of whether the disease term appears in the title and whether
the publication type is clinical trial are categorical, i.e., 0 or 1, and all the
other features are numerical because we simply count the term frequency of
each keywords.
Table 4. Features in the classifier
Feature Description Data Type
Whether the disease name appears in the title Categorical
How many positive keywords appear in the title Numerical
How many positive keywords appear in the abstract Numerical
How many negative keywords appear in the title Numerical
How many negative keywords appear in the abstract Numerical
Whether the publication type is about Clinical Trial Categorical
How many heading keywords appear in the heading Numerical
The next step is to generate the positive keywords, negative keywords and
heading keywords for counting. Oleynik et al. use the Latent Dirichlet Alloca-
tion (LDA) model to do Topic Modeling (TM) among the relevant articles and
non-relevant articles to find positive and negative keywords which are strongly
correlated to these two corpuses [25]. Besides the LDA model, we also explore
the simple TF-IDF weights of keywords in these two types of corpuses, and the
heading keywords are generated in this way as well. These keywords are sup-
posed to have the biggest correlations to the certain corpus. The lists of positive,
negative and heading keywords are shown in Table 5.
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Table 5. Positive, negative and heading keywords
Positive Keywords treatment, survival, prognostic, clinical, prognosis, therapy
outcome, resistance, targets, therapeutic, immunotherapy
Negative Keywords pathogenesis, tumor, development, model, tissue, mouse
specific, staining, dna, case, combinations
Heading Keywords Humans, Mutation, genetics, drug therapy, metabolism
drug therapy, pharmacology, antagonists & inhibitors
drug effects, therapeutic use, immunology
3.4 Ranker Construction
We train a Logistic Regression model to predict the probability that a document
is relevant to the PM track. All the hyperparameter settings are as default in
the Python scikit-learn11 library. For each retrieved article, the feature vector
is generated based on the feature table above and the probability of a positive
(relevant) label is predicted using the logistic regression model.
We use both the predicted probability of how relevant an article is to the PM
track and the original BM25 score for re-ranking, as the experiment result con-
firms our hypothesis that purely using the probability and ignoring the ranking
from original scores do not work very well. However, since the probability is a
number between 0 to 1 and the original BM25 score could be as large as 70, we
should keep them at the same scale. Therefore, we do the min-max transforma-
tion on the original BM25 score and it is thus scaled to a number between 0 to
1, which makes it more reasonable to add the probability to the original score.
Then for each article, a new score is generated by adding up the raw BM25 score
and the probability from the classifier, finally the re-ranking is based on new
scores.
However, in experiments we find that applying the reranker to all the 1000
results do not improve the precision, but hurt the performance instead. We
suppose that it is because the positive instances in the training set merely come
from past teams’ top retrieved results, which are much fewer than the negative
instances. In other words, since there are 26.8 million articles in the corpus, it
is impossible for people to manually label each document as relevant or non-
relevant. Thus, the ad-hoc relevance judgment by experts are only applied on
documents which rank at top in each team’s submitted results, which leads to
a different distribution of instances in the training and testing set. Therefore,
instead of applying the reranker on all the 1000 retrieved documents to do re-
ranking, we only re-rank the top 50 documents, after testing different top K
documents to re-rank by optimizing P@10 on the 2017 topics.
In summary, we train the reranker on the 2017 topics and find that the
optimal number to re-rank is 50. When we run queries on the 2018 topics, we
follow the heuristic approach first, i.e., we punish a document which does not
11 https://scikit-learn.org/
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mention the disease term in its title by multiplying its raw score by a penalty
factor of 0.6, based on which the results are re-ranked for the first time. We then
transform the raw BM25 scores using a min-max scaler to a number between 0
and 1. Afterwards, we only input the top 50 documents into the reranker and add
up BM25 scores with the probability, and keep scores of the other 950 documents
unchanged. Based on new scores, the re-ranking is done for the second time and
a final ranked list is returned for relevance judgment.
4 Experiment
In this section, we discuss the performances of different retrieval strategies and
methods. We first introduce the dataset which is used in this paper, and then
show how a query is generated for each topic. We then compare retrieval per-
formances in the result section followed by three case studies and some other
approaches which fail to show improvements but may work in the future.
4.1 Dataset Overview
As is discussed in previous sections, we use the dataset which consists of 26.8
million MEDLINE articles and 70,026 ASCO/AACR conference articles as cor-
pus, and all these articles only contain the abstract part instead of the full text
which is referred to as the content field in this paper. The indexing process takes
about 8 hours on a research computing node with 16 core CPU and 100 gigabytes
RAM, and the file size of indexes is about 18 gigabytes.
There are 30 topics in the 2017 track and 50 topics in the 2018 track, both
are in the XML format and each node represents a patient with disease, gene
and demographic information (see Figure 2).
Fig. 2. A query topic
4.2 Query Structure
For each topic, we generate the query using the disease and gene information,
and the demographic information is not used in this paper. After these two
fields are expanded in knowledge bases, weights are assigned to each term. We
use the OR operator between all the terms, because it is impossible for a paper
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to contain all the query terms after expansion. We use the SHOULD operator
for the title field and the MUST operator for the content field, which means it
is not required for a document to match the query in its title but required to
match the query in its content.
4.3 Result and Implications
Our final query structure and weights for each expansion part are shown in Table
6. We keep weights of the original disease and gene terms always as 1, and we
set weights of all the expansion terms to 0.3 initially. To optimize Recall@1000,
we control the weight of other expansion terms in the query as the same and
tune one part to an optimized recall.
The final weights are in accord with our expectations. A disease has 3 or 4
preferred terms and synonyms in total, and these terms usually contain several
words (see Table 2). Also, when we examine the output, we find that some
expansion terms may not appear in the whole corpus because they are too rare,
or not be relevant to the original disease. Therefore, the weight of these expansion
terms should not be too high to shift the focus of the original query and it is thus
set to 0.1. However, the weight of disease acronyms is 0.5 because it is highly
related or even equivalent to the original disease. The weight for gene aliases is
fairly 0.3.
Table 6. Weights for each term which optimizes R@1000
Field Query Term Weight
Diseases Original Disease Term 1
Disease Preferred Term 0.1
Disease Synonyms 0.1
Disease Acronyms 0.5
Genes Original Gene Term 1
Gene Aliases 0.3
The comparison between different retrieval strategies is shown in Table 7. We
run five retrievals in total and we describe the settings for each retrieval below.
To be more specific, Retrieval I & II are used to test the hypothesis that
query expansion is useful, and these two retrievals are different in the structure
of expansion terms. And based on Retrieval II which optimizes Recall@1000,
Retrieval III & IV are used to test the hypothesis that re-ranking is effective,
and these two retrievals are different in the re-ranking method, with the heuristic
and learning-to-rank approach separately. In Baseline and Retrieval I, II, III
& IV strategies, a same setting is used that terms are connected using the OR
operator, and the operators for the title and content field are SHOULD and
MUST separately.
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Table 7. Comparison between retrieval strategies
Retrieval Strategy R@1000 P@10 R-prec
Baseline 0.686 0.544 0.317
Retrieval I 0.695 0.554 0.299
Retrieval II 0.702 0.568 0.320
Retrieval II 0.702 0.618 0.322
Retrieval IV 0.702 0.646 0.336
hpi-dhc - 0.706 0.365
Cat Garfield - 0.668 0.325
SIBTextMining - 0.632 0.357
Baseline: This serves as the most basic strategy in our approaches. In this
retrieval, we use only the original disease and gene terms in the topic without
query expansion and re-ranking.
Retrieval I: In this retrieval, the disease term is expanded to its preferred
term and synonyms, and the gene term is expanded to its aliases, with weights
assigned shown in Table 6.
Retrieval II: Compared to previous retrieval, acronyms of diseases are added
into the expansion terms, with weights assigned shown in Table 6.
Retrieval III: Compared to Retrieval II, the re-ranking step is added after
the first retrieval with the heuristic approach.
Retrieval IV: Compared to Retrieval II, the re-ranking step is added after
the first retrieval with the trained reranker.
In summary, Retrieval I & II prove that adding expansion terms into the
original query for diseases and genes is helpful, as they improve Recall@1000
from 0.686 to 0.695 and 0.702 separately, which means more potentially relevant
documents are being matched because of these expansion terms. The higher
recall in Retrieval II over that in Retrieval I illustrates that acronyms are
important in expansion. Also, with a wise selection of weight parameters in the
query expansion step, P@10 is not hurt and, instead, improved from 0.544 to
0.554 and 0.568 separately. This result supports that high-quality expansion
terms could help to improve both recall and precision.
Based on Retrieval II which optimized Recall@1000, Retrieval III & IV
prove that the re-ranking step improves precision by pushing the most relevant
documents to the top. Retrieval III shows that the heuristic approach which
penalizes documents without disease term in the title already works well, as
P@10 increases from 0.568 to 0.618, considering its simplicity. Retrieval IV
proves that a Logistic Regression reranker further helps to improve the precision,
as the precision is 0.1 higher than the baseline approach and 0.026 higher than
the heuristic approach.
In Table 7, we include retrieval performances from three top-ranking teams in
the 2018 PM track as well. Team hpi-dhc, Cat Garfield and SIBTextMining have
the highest P@10 among all the teams. The extreme high precision of team hpi-
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dhc and Cat Garfield benefits from their domain knowledge. Team hpi-dhc make
hand-crafted rules for documents matching in retrieval, and they pre-process the
corpus in their own framework, which is an edge over our practice of indexing
the raw text [25]. Team Cat Garfield construct their own knowledge graph by
integrating several knowledge bases together, and this high-quality knowledge
graph proves its power in both query expansion and re-ranking. Also, they train
a CNN classifier for re-ranking, which is more complicated but has a better per-
formance than our linear classifier [24]. Unfortunately, team SIBTextMinining
does not provide a report of their work. It is highlighted that with query expan-
sion in a publicly available knowledge base and a linear classifier for re-ranking,
the Precision@10 in this paper already ranks at the third place among all the
teams.
4.4 Case Studies
To further demonstrate how query expansion and re-ranking help to improve
the retrieval performance clearly, in this section we present case studies with
examples to illustrate how these two steps enhance retrieval in Case I & II.
We also give an error analysis case to discuss why our retrieval architecture fails
to handle some tough and ambiguous situations in Case III. Considering the
length of full texts, we only provide snippets in this section and full abstracts
could be found at the Appendix.
Case I: The contribution of query expansion.
As is discussed in previous sections, the motivation of query expansion is to
enrich query information by adding into the query alternative or relevant terms
of the original keywords, and it is expected to match some potentially relevant
documents which do not contain those original keywords. Hereby we show the
contribution of query expansion with an article which is not retrieved in the
baseline model but is retrieved after the query expansion technique is used.
Fig. 3. A query topic
As is shown in Figure 3, topic No.36 aims to find relevant articles about lung
cancer and the ERBB2 gene. And below is the snippet of one paper’s abstract
(PubMed ID: 14981584) which is relevant to this topic. It demonstrates how
expanding disease and gene terms helps to retrieve more relevant documents.
“Title: The role of HER-2/neu expression and trastuzumab in
non-small cell lung cancer.
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Abstract: ... The HER-2/neu receptor... HER-2/neu is overex-
pressed in 16% to 57% of patients with non-small cell lung can-
cer (NSCLC) and studies have shown that HER-2/neu overex-
pression imparts a poor prognosis in both resected and advanced
NSCLC, as it does in ... the HER-2/neu protein receptor, has
been ... with HER-2/neu-positive metastatic breast cancer. In
NSCLC preclinical studies, marked synergistic ... in HER-2/neu-
expressing cell lines. However, to date, clinical studies with trastuzumab
in patients with NSCLC have not shown a demonstrable advan-
tage ...”
As we can see from this example, this paper does not talk about the ERBB2
gene at all, but it mentions HER-2/neu which is an alias of ERBB2 throughout
the abstract. This paper is not retrieved in the baseline strategy because of
the mismatch between the original gene term and gene terms in the content.
However, it is retrieved after the gene term is expanded to its aliases, i.e., the
expansion term HER-2/neu is included into the query. Also, this paper does not
talk about the original disease term lung cancer, but one of its synonyms which
is non-small cell lung cancer and its acronym NSCLC are used five times in total
merely in the snippet above. If the disease is not expanded to its preferred term,
synonyms and acronym, this paper would not be retrieved because of the low
term frequency of the disease term lung cancer. By query expansion, recall@1000
for this topic is thus improved from 0.19 in the baseline approach to 0.48.
Case II: The contribution of re-ranking.
As is discussed in previous sections, the motivation of re-ranking is to push
a relevant document with a low raw score and low ranking to the top, and
also to lower the rankings of non-relevant documents. It is expected to increase
precision at the top, e.g., Precision@10 used in this paper. In this case, we show
the contribution of the re-ranking step with one example that is not in the top
10 results initially but does appear in the top 10 list after re-ranking, and with
another example which is punished to a rank after 10. We use the same topic as in
the previous case, i.e., lung cancer and the ERBB2 gene. It shall be highlighted
that the original Precision@10 for topic No.36 is 0.2, and the new Precision@10
for this topic is increased to 0.5 after re-ranking.
In the re-ranking section, we propose two methods which are a heuristic
approach and a learning-to-rank approach, and examples are given for both
methods. We first show how the heuristic approach decreases scores of non-
relevant documents which do not mention the disease term in the title. There
are 8 non-relevant documents in the initial top 10 list, and none of them appears
in the new list after re-ranking. For the sake of simplicity, we give only one
example in Table 8.
As is shown in Table 8, a top-ranking article (PubMed ID: 12755489) is
now going down to 47 although it ranks as high as 4 initially, because the topic
disease lung cancer does not appear in its title.
It is not hard to tell from the title that this article is not about lung cancer
at all, it should all about breast cancer instead. But why could this obviously
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Table 8. An example of punishing non-relevant documents
Document Title Raw Score New Score Raw Rank New Rank
HER-2/neu and topoisomerase 61.8 37.08 4 47
IIalpha in breast cancer
non-relevant article be retrieved? From the snippet of its abstract below, it is
revealed that the high-ranking raw score purely comes from the extremely high
term frequency of the gene HER-2/neu. Simple as the heuristic approach is, it
still helps to refine the top results.
“Abstract: ... The HER-2 (also known as ErbB2/c-erbB2/HER-
2/neu) oncogene is the most frequently ... HER-2 is also a target
for ... HER-2 receptor. HER-2 has also been implicated ... by
the HER-2 ... of the HER-2 amplified primary breast tumors ...
of HER-2 amplification also ... HER-2 is an oncogene that ...
other than HER-2, such as ... HER-2 status still ... importance
of HER-2 ...”
The heuristic approach proves its usefulness in punishing non-relevant docu-
ments above, and we give another example of how a relevant document (PubMed
ID: 15312350) is boosted to top 10 after re-ranking using the learning-to-rank
approach. As is shown below, this document is not punished because it mentions
the topic disease lung cancer in its title. Also, from the snippet of its abstract,
we could see that it is boosted because of the high term frequency of positive
keywords prognostic and survival in both its title and content, which indicates
that this paper focus on treatments and is in accord with the PM track. Its ac-
tual rankings go with our expectations: its raw score ranks at 16; its probability
ranks at 6 and its final score after adding two up ranks at 7.
“Title: Prognostic value of expression of FASE, HER-2/neu, bcl-2
and p53 in stage I non-small cell lung cancer
Abstract: To evaluate the prognostic value of expression of fatty
acid synthase (FASE), .... The 5-year survival rate was lower in
HER-2/neu and FASE positive patients than in negative patients,
which showed that HER-2/neu and FASE expression were associ-
ated with significantly poor survival ... with a 5-year survival
rate of 78.2% ... prognostic factors for survival. HER-2/neu and
FASE are independent prognostic factor in stage I non-small cell
lung cancer ...”
Case III: Error Analysis. Although retrieval results in two previous sections
have proven that both query expansion and re-ranking are useful in improving
the retrieval performance, there are two situations that our proposed retrieval
architecture fail to handle. One is that a non-relevant document is retrieved and
ranked among the top 10 list, and another is that a relevant document is not
retrieved or does not rank in the top 10 list, which could be recognized as cases
of false positive and false negative, respectively. Hereby we do an error analysis
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of these two situations with two examples, from which we investigate the flaw of
our retrieval architecture for future improvements. And we still use topic No.36
which is about lung cancer and the ERBB2 gene as above.
We first take a look at one example of the false positive cases, which means
that the document below (PubMed ID: 22730705) is non-relevant to the topic
but still ranks among the final top 10 results. It ranks at 39 if sorted by the raw
score because of its fairly high term frequency of both disease and gene terms.
However, it ranks at 5 if sorted by the probability from the reranker, for there
are 8 positive keywords in total and no negative keywords at all, which could
be seen from the snippet below. Also, the disease term appearing in the title
ensures that it is not punished. Since the raw is transformed in a min-max scale,
the raw score gap between this document and other documents is shortened,
and it finally ranks at 8 in the final result. A close look at this article reveals
that it focuses on predicting cancer patients’ survival rather than developing or
evaluating cancer treatments. This makes it non-relevant to the central goal of
PM track.
“Title: HER-2/neu oncogene and estrogen receptor expression in
non small cell lung cancer patients
Abstract: ... The prognosis is usually ... parameters and clini-
cal stage, but additional prognosis survival factors ... of HER-
2/neu and estrogen receptors in nonsmall cell lung cancers
and their relation to survival of patients with non-small cell
lung cancers and to traditional prognostic factors ... resected
patient tissues of non-small cell lung cancers, and the following
parameters were examined: HER-2/neu and estrogen receptor ex-
pression, as well as the related clinical and pathological features
... Our findings indicate that the expression of HER-2/neu ... the
survival of patients with non-small cell lung cancers.”
Apart from the false positive situation, we give another example of the false
negative cases, which means that the document below (PubMed ID: 11153605)
is relevant to the topic but does not rank among the final top 10 results. Its raw
score ranks at 9, which is much higher than the non-relevant document above.
It is not only because the high term frequency of disease and gene terms, but
more importantly, the gene mentioned in this paper is the original term ERBB2,
which has a higher weight than the expansion term HER-2/neu, i.e., the weight 1
comparing to the weight 0.3. However, it ranks at 14 if sorted by the probability
from the reranker, for there are only 3 positive keywords and also two negative
keywords case. Therefore, after adding the raw score and the probability up, this
article ranks at 13 in the final result.
“ Title: Ploidy, expression of erbB1, erbB2, P53 and amplification
of erbB1, erbB2 and erbB3 in non-small cell lung cancer.
Abstract: ... assess the prognostic value of ... erbB2 ... in non-
small cell lung cancer (NSCLC). Consecutive patients with
NSCLC who underwent treatment... In 108 cases, ... In another
108 cases, ... determined in the tumours of 53 patients ...18% for
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erbB2 ... 94% for erbB2 ... erbB2 and P53 expression ... stage
... erbB2 ... not prognostic parameters in non-small cell lung
cancer ...”
From these two errors, together with the retrieval compassion in Table VII, we
can see that although adding the probability helps to improve precision, it could
still make mistakes, especially when a non-relevant document has more positive
keywords, or a relevant document has more negative keywords. This implies that
the features of simply counting positive or negative keywords in title or abstract
are not robust or may not work in some cases. Also, these two errors also suggest
that simply adding the raw BM25 score and the probability may not work, as
we can see the non-relevant document ranks higher largely because of its high
probability, and the relevant document ranks lower because of low probability.
Therefore, a more reasonable weighting should be investigated.
4.5 Other Trials
Apart from the retrievals discussed above which give the expected performances,
we also try other approaches both in the query expansion step and the re-ranking
step. Unfortunately, all these approaches do not show improvements of the re-
trieval result, some of which even lead to a worse performance than the baseline
approach. Hereby we present these trials with the intuition behind and error
analysis, which could be used for future work references.
Trail I: We use other knowledge bases like MeSH, Orphanet12, Disease On-
tology13, and Wikidata14 for disease query expansion. However, diseases terms
expanded by these knowledge bases either are too far from the original disease
to be relevant, i.e., some rare diseases or terms which are abandoned and not
used anymore, or have only minor changes in the order of words or simply to
the plural form, e.g., Colonic Neoplasms in MeSH has the preferred term of Neo-
plasm, Colonic. The result of adding these low-quality expansion terms shows
that R@1000 is slightly improved and P@10 is hurt because all the disease ex-
pansion terms contain almost same words, which lead to an implicit boost of
these duplicate words and shift the focus of the original query. Even though
we remove duplicate words in the expanded query by using unique terms, the
result still shows that R@1000 is still slightly improved. Therefore, we choose
the Lexigram knowledge base for query expansion.
Trail II: We add parent, children and siblings of a disease as expansion
terms when using the MeSH knowledge base, for MeSH is an ontology in a tree
structure. We hypothesize that some relevant articles may not talk about the
disease, but about the parent of the disease in the tree which are broader or
the children which are more specific. We even consider the siblings of a disease
in the tree structure. However, even we do a lot of work on parameter tuning,
the results show that adding these expansion terms hurts both R@1000 and
12 https://www.orpha.net/consor/cgi-bin/index.php
13 http://disease-ontology.org/
14 https://www.wikidata.org/wiki/Wikidata:Main_Page
25
P@10. It is probably because these expansion terms are too broad or specific
to be relevant, which adds noises to the query. We then hypothesize that the
presence of parent, children or sibling diseases could be feature in re-ranking,
and we generate the feature by counting how many these terms occur in the
text. However, the result proves that the reranker without this feature works
better. After reading about 30 relevant articles, we found only 2 of them contain
these parent or children disease terms.
Trail III: We change the operator for the title field from SHOULD to MUST.
We hypothesize that setting a strict matching criterion that the title field must
contain the terms in the query would improve the precision at one-time retrieval
and skip the re-ranking part. However, the results show that both P@10 are
not improved, and because of the strict criterion, there are much fewer results
retrieved.
Trail IV: We boost the title field with weight 2, comparing to the content
field having weight 1 without boosting. We hypothesize that the title field should
be more important than the content filed, with the intuition that if an article
mentions the disease or gene terms in the title, it might be more relevant to the
topic. However, the results show that it hurts both R@1000 and P@10. When
reading some articles in the corpus, we find some irrelevant articles also contain
the disease or gene terms in the title, and these irrelevant articles are pushed to
the top after we boost the title field.
Trail V: We return the abstract text in the retrieved result and then use
the Pubtator15 application to do Named Entity Recognition in text to recognize
disease and gene terms. Inspired by the bag-of-words model, we use the bag-
of-concepts model along with the PRF method to do re-ranking by running a
query in the retrieved articles. The vector space model and the TF-IDF weighting
representation of concepts are used in this step.
We first construct the corpus of all the diseases and genes, then each article
is represented by a vector containing disease and gene terms. We then generate
the query vector for re-ranking by adding the average vector of top K articles
to the vector of the original disease and gene terms. We compute the cosine
similarity between the query vector and other article vectors, and the articles
are ranked according to their similarities to the query. However, it is a time-
consuming step because there are several parameters to be tuned, which are
how many top ranked documents should be used for averaging, what weights of
the original query vector and the averaged query vector should be when adding
them up. Although we spend a lot of time tuning these parameters, the optimal
results in this strategy are still not as good as expected, which shows only a
slight improvement of P@10.
Trail VI: We add positive and negative keywords in the query and give
these terms a boost or a penalty. We hypothesize that articles which focus on
treatment, clinical study and patients should be more relevant that articles which
focus on laboratory experiments. Therefore, we added some keywords suggest by
Oleynik et al. [25] into the query to boost documents with positive keywords and
15 https://www.ncbi.nlm.nih.gov/CBBresearch/Lu/Demo/PubTator/
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penalize documents with negative keywords. However, Lucene does not support
negative boost for a query term. Therefore, we use these keywords as our features
to train the Logistic Regression classifier in the re-ranking step.
Trail VII: We leverage the disease-gene connections for query expansion
and add other variations of a gene. Although the Lexigram knowledge base and
the gene database has proved that it works well in the query expansion step
and provide comprehensive expansion terms, the expansion is still based on the
disease or gene itself. In other words, we are still starting from a disease or a gene
and investigating what relevant terms are, e.g., preferred terms and synonyms.
However, we hypothesize that some totally different diseases could be relevant
if they are caused by similar genes, and some totally different genes could be
relevant if they cause similar diseases, which means we are digging into the latent
relations. Many teams have successfully incorporated the knowledge bases of
disease-gene-drug relations into the query expansion. Inspired by this idea, we
use the DisGeNet16 knowledge base which contains relations between diseases
and genes and transform the knowledge graph to a matrix of diseases and genes
with each element in the matrix representing the probability that a gene and a
disease are correlated. Thus, each disease and gene could be represented by a
vector and pairwise cosine similarities between vectors could be calculated.
Given a disease or a gene, the relevant terms are generated by sorting the
similarities in a descending order. Then we add the top K relevant terms in the
query as expansion terms. However, the results show that it does not help to
improve R@1000. After examining the expansion terms, we find most expansion
terms generated which even rank at the top 5 still have poor similarities, which
means they share few diseases or genes information in common. We view this
as a potential approach to generate expansion terms, or could be used in the
re-ranking step in the future work.
5 Conclusions
Medical literature search has long been suffering from the problems of vocabulary
mismatch between queries and documents and ineffective ranking methods as
well, which makes the traditional Boolean retrieval deliver both low recall and
precision. In this paper, we use external knowledge bases in the medical domain
to expand the query automatically, which enriches the information in the original
query without manual input. This helps the query to match documents without
terms from the original query. After the first retrieval, we use a ranker which is
trained on the 2017 track topics to predict the probability of how relevant the
retrieved document is. Then the retrieved results are ranked by the probability.
The experiment results prove that both these two steps help to improve the
retrieval performance, and the final model outperforms the baseline model in
both recall and precision. The future work could be in the directions discussed
below. First of all, although the Lexigram knowledge base provides well rounded
16 http://www.disgenet.org/home/
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expansion terms for diseases and outperforms the MeSH ontology, it is possible
there exists a knowledge base which provides higher-quality expansion terms.
And as is discussed in the literature review section, there has been some studies
which focus on the selection of expansion terms instead of adding all of them.
The refinement of query expansion terms could be further studied in the future.
Secondly, since the reranker is trained on the 2017 topics, it could be trained
again on both 2017 and 2018 topics together when it is applied to the 2019
PM track. With more training data and better feature generation and selection,
we expect the reranker to have a better performance and avoid mistakes in the
case study section, which is expected to improve the precision further. Also, in
training the reranker we are on the level of the whole corpus, and predicting
whether an article is relevant to the general PM track rather than to the topic.
We hypothesize that there are some features representing the connection between
the article and the topic, which makes the classification more specific to each
topic. And the case study of error analysis reminds us that the new scoring
schema is also a direction of improvement, which could be changed from simply
adding the probability and the raw BM25 score to a weighted sum because either
the raw score or the probability may be more important than another, or merging
two ranks could also work.
Third, as there are both gene and disease information in the topics, we could
leverage the connections between diseases and genes (e.g. how strongly a disease
and a gene are connected to each other) for relevance judgment by using a
knowledge graph. This is a failed trial in this paper, but it still gives us some
inspirations.
Last but not least, we use high-level features with a linear model in training
the reranker, and it is possible that the deep learning approach could also work.
For example, we could train word vectors for a deep Neural Network classifier.
6 Appendix
Case I: A paper which is retrieved after query expansion
PubMed ID: 14981584
Title: The role of HER2/neu expression and trastuzumab in non-small cell
lung cancer
Abstract: Research over the past decade has led to an increased understand-
ing of the pathophysiology of lung cancer. The HER2/neu receptor is a member
of the ErbB family of signaling-transduction receptors and appears to play a
major role in the development of lung cancer as well as many other solid tu-
mors. HER2/neu is overexpressed in 16% to 57% of patients with non-small cell
lung cancer (NSCLC) and studies have shown that HER2/neu overexpression
imparts a poor prognosis in both resected and advanced NSCLC, as it does in
breast cancer. Trastuzumab, a humanized monoclonal antibody that recognizes
the HER2/neu protein receptor, has been approved by the US Food and Drug
Administration for patients with HER2/neu-positive metastatic breast cancer. In
NSCLC preclinical studies, marked synergistic growth inhibition occurred when
28 J. Qu and Y. Wang
standard cytotoxic chemotherapy was combined with trastuzumab in HER2/neu-
expressing cell lines. In the clinical setting, trastuzumab has proven safe and
feasible in combination with cytotoxic chemotherapy in both single-institution
and multi-institutional cooperative group studies. Unlike the experience in ad-
vanced breast cancer, cardiac toxicity is a marginal concern in this population.
However, to date, clinical studies with trastuzumab in patients with NSCLC
have not shown a demonstrable advantage for the majority of patients.
Case II: A non-relevant paper which is punished in re-ranking
PubMed ID: 12755489
Title: HER-2/neu and topoisomerase IIalpha in breast cancer
Abstract: In breast cancer, the predominant genetic mechanism for oncogene
activation is through an amplification of a gene. The HER-2 (also known as
ErbB2/c-erbB2/HER-2/neu) oncogene is the most frequently amplified oncogene
in breast cancer, and its overexpression is associated with poor clinical outcome.
In addition to its important role in breast cancer growth and progression, HER-2
is also a target for a new form of chemotherapy. Breast cancer patients have been
treated with considerable success since 1998 with trastuzumab, a recombinant
antibody designed to block signaling through HER-2 receptor. HER-2 has also
been implicated in altering the chemosensitivity of breast cancer cells to different
forms of conventional cytotoxic chemotherapy, particularly of topoII-inhibitors
(e.g., anthracyclines). Topoisomerase IIalpha gene is located just by the HER-2
oncogene at the chromosome 17q12-q21 and is amplified or deleted in almost
90% of the HER-2 amplified primary breast tumors. Recent data suggests that
amplification and deletion of topoisomerase IIalpha may account for both rela-
tive chemosensitivity and resistance to anthracycline therapy, depending on the
specific genetic defect at the topoIIalpha locus. Expanding our understanding of
HER-2 amplification also changes its role in the pathogenesis of breast cancer.
HER-2 is an oncogene that clearly can drive tumor induction and growth and
is also a target for a new kind of chemotherapy, but its function as a marker
for chemoselection may be due to associated genetic changes, of which topoi-
somerase IIalpha is a good example. Moreover, despite potential evidence that
genes other than HER-2, such as topoisomerase IIalpha, may be more impor-
tant predictors of therapeutic response in breast cancer, HER-2 status still has
a very significant role in therapeutic selection, mainly as the major criterion
for administering trastuzumab in treating breast cancer. Thus, the clinical and
therapeutic importance of the HER-2 and topoisomerase IIalpha status to breast
cancer management should only increase in the next few years.
Case II: A relevant paper which is boosted in re-ranking
PubMed ID: 12755489
Title: Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in
stage I non-small cell lung cancer
Abstract: To evaluate the prognostic value of expression of fatty acid syn-
thase (FASE), HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer
(NSCLC). Expression of FASE, HER-2/neu, bcl-2 and p53 protein was detected
by immunohistochemical staining in 84 patients with stage I NSCLC who un-
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derwent surgery. Multiple clinical parameters and survival were analyzed. The
expression of FASE, HER-2/neu, bcl-2 and p53 was 29.8%, 40.5%, 33.3% and
39.3%, respectively. The local recurrence and bone-metastasis rate were higher
in FASE positive patients than in negative patients (28.0% vs 10.2%, P = 0.05;
61.5% vs 23.9%, P = 0.017, respectively). The 5-year survival rate was lower
in HER-2/neu and FASE positive patients than in negative patients (37.7% vs
67.7%, P = 0.0083; 35.1% vs 66.1%, P = 0.0079, respectively), which showed
that HER-2/neu and FASE expression were associated with significantly poor
survival. Patients whose tumors were both HER-2/neu and FASE negative had
better outcome, with a 5-year survival rate of 78.2%, compared with 36.3% in
those whose tumors were positive for either one (P = 0.002). However, bcl-2 and
p53 were not independent prognostic factors for survival. HER-2/neu and FASE
are independent prognostic factor in stage I non-small cell lung cancer patients
who expressed one or both markers.
Case III: A non-relevant paper which ranks among top 10
PubMed ID: 22730705
Title: HER-2/neu oncogene and estrogen receptor expression in non small
cell lung cancer patients.
Abstract: Non-small cell lung cancers are among the leading causes of cancer
morbidity and mortality worldwide. The prognosis is usually based on tradi-
tional pathohistological parameters and clinical stage, but additional prognostic
survival factors have also been sought. The aim of this retrospective study was to
explore the membranous expression of HER-2/neu and estrogen receptors in non-
small cell lung cancers and their relation to survival of patients with non-small
cell lung cancers and to traditional prognostic factors. The sample consisted of
132 consecutive, surgically resected patient tissues of non-small cell lung cancers,
and the following parameters were examined: HER-2/neu and estrogen receptor
expression, as well as the related clinical and pathological features: tumor, nodes,
and metastases stage, level of tumor necrosis, histological and nuclear grade, lym-
phocytic infiltrate, and number of mitoses. HER-2/neu was positive in 28.8% of
tumor samples, and estrogen receptor expression was positive in 29.5% of tu-
mors, but neither was significantly associated with the outcome of non-small
cell lung cancers. There was a significant association between HER-2/neu and
nuclear grade (P=0.01). In addition, the association between estrogen receptor
expression and histological type of tumor (P=0.04) and mitotic rate (P=0.008)
was found. Kaplan-Meier analysis showed a significant association of patients’
overall survival with the tumor node metastasis stage (P<0.001) and the degree
of tumor necrosis (P=0.02). Cox proportional hazard regression analysis showed
that male gender (P=0.01), histological type (P=0.03), high degree of necrosis
(P=0.006), and higher histological grade (P=0.037) were associated with the
patients’ survival. Our findings indicate that the expression of HER-2/neu and
estrogen receptor is less reliable than traditional histological parameters in pre-
dicting the survival of patients with non-small cell lung cancers.
Case III: A relevant paper which does not rank among top 10
PubMed ID: 11153605
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Title: Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1,
erbB2 and erbB3 in non-small cell lung cancer.
Abstract: The aim of this study was to assess the prognostic value of deoxyri-
bonucleic acid analysis, expression oferbB1, erbB2 and P53, and amplification
levels of erbB1, erbB2 and erbB3 in non-small cell lung cancer (NSCLC). Con-
secutive patients with NSCLC who underwent treatment with curative intention
(118) were included. In 108 cases, the cell cycle was analysed using flow cytometry
and double-staining with propidium iodide and anticytokeratin. In another 108
cases, expression of erbB1, erbB2 and P53 was assessed immunhistochemically.
Amplification of the erbB family was determined in the tumours of 53 patients
using double-differential polymerase chain reaction. Of the tumours, 81% were
aneuploid and 14% showed positive staining for erbB1, 18% for erbB2 and 41%
for P53. There were normal mean gene copy numbers in 86% for erbB1, 94%
for erbB2 and in 96% for erbB3. No significant correlations were noted between
erbB1, erbB2 and P53 expression, ploidy status and tumour stage. In a Cox
regression model, only tumour stage was shown to be prognostically significant.
It seems that ploidy and expression status of erbB1, erbB2 and P53 are not
prognostic parameters in non-small cell lung cancer. Amplification of the erbB
family does not seem to be a frequent event in non-small cell lung cancer.
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